Ditchcarbon
  • Contact
  1. Organizations
  2. PendoPharm Inc.
Public Profile
Pharmaceutical Preparation Manufacturing
CA
updated 3 months ago

PendoPharm Inc. Sustainability Profile

Company website

PendoPharm Inc., a prominent player in the pharmaceutical industry, is headquartered in California and operates extensively across North America. Founded in 2015, the company has quickly established itself as a leader in the development and distribution of innovative healthcare solutions, particularly in the areas of specialty pharmaceuticals and medical devices. PendoPharm's core offerings include a range of unique products designed to address unmet medical needs, with a focus on improving patient outcomes. The company is recognised for its commitment to quality and efficacy, which has solidified its position in a competitive market. With a strong emphasis on research and development, PendoPharm continues to achieve significant milestones, contributing to advancements in healthcare and enhancing its reputation as a trusted partner in the industry.

DitchCarbon Score

How does PendoPharm Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

PendoPharm Inc.'s score of 23 is lower than 69% of the industry. This can give you a sense of how well the company is doing compared to its peers.

31%

Let us know if this data was useful to you

PendoPharm Inc.'s reported carbon emissions

PendoPharm Inc., headquartered in California, currently does not report any specific carbon emissions data, as there are no available figures for emissions in kg CO2e. The company has not established documented reduction targets or climate pledges, indicating a lack of formal commitments to address carbon emissions at this time. As a current subsidiary, PendoPharm Inc. may inherit climate-related initiatives and targets from its parent organisation, but specific details regarding these cascaded commitments are not provided. Without concrete emissions data or reduction initiatives, it is challenging to assess PendoPharm's climate impact or commitments within the broader industry context.

How Carbon Intensive is PendoPharm Inc.'s Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. PendoPharm Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is PendoPharm Inc.'s Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for PendoPharm Inc. is in CA, which has a very low grid carbon intensity relative to other regions.

PendoPharm Inc.'s Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

PendoPharm Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare PendoPharm Inc.'s Emissions with Industry Peers

UserTesting

US
•
Machinery and equipment n.e.c. (29)
Updated 9 days ago

Amplitude

US
•
Computer and related services (72)
Updated 20 days ago

Rocca & Partners Stichting Administratiekantoor Aandelen San Faustin

NL
Updated 9 days ago

HLS Therapeutics Inc.

CA
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Astra Tech GesmbH (Austria)

AT
Updated 3 months ago

Let us know if this data was useful to you

Usage Policy

You're welcome to quote or reference data from this page, but please include a visible link back to this URL.

Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.

See our License Agreement for more details.

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251209.2
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
Available onAWS Marketplace logo
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
Use CaseSBTi-aligned baselining & progress trackingSupplier EngagementClimate-informed sourcing strategyEmission ReportingSustainable Finance
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelogWhitepaper
AboutTeamCareersLicense AgreementPrivacy